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Abstract Congenital heart disease (CHD) is the most
common birth defect in humans. The genetic causes of
sporadic CHD remain largely unknown. Bone morphoge-
netic protein 4 (BMP4), a member of the transforming
growth factor-b (TGF-b) family, is required for normal
heart development. Loss of BMP4 gene expression in mice
is associated with septal defects, defective endocardial
cushion remodeling, and abnormal semilunar valve for-
mation. This study evaluated the contribution of single
nucleotide polymorphisms (SNPs) in BMP4 to CHD sus-
ceptibility in a case–control study of 575 patients with
CHD and 844 non-CHD control subjects in a Chinese
population. The BMP4 SNP rs762642 was associated with
CHD in an additive model (odds ratio [OR]add 1.22; 95 %
confidence interval [CI] 1.04–1.43; Padd = 0.02). Stratified
analysis by CHD subtypes showed a significant association
only between rs762642 and atrial septal defect (ORadd
1.33; 95 % CI 1.04–1.72; Padd = 0.03) in the additive
model. This study was the first to indicate that a common
variant of BMP4 may contribute to susceptibility to spo-
radic CHD in a Chinese population.
Keywords Congenital heart disease  Single nucleotide
polymorphism  Bone morphogenetic protein 4
Introduction
Congenital heart disease (CHD) is a leading cause of
perinatal mortality, with an incidence of approximately 6–8
in 1,000 live births [6]. For classification of CHD, three
broad categories have been defined: the more common
septation defects, cyanotic heart disease, and left-sided
obstruction defects [1]. However, the proportion of each
category varies greatly among geographic regions.
The origin of CHD is complex and involves both envi-
ronmental and genetic factors. Recognizable chromosomal
variants account for 13 % of all CHD patients, whereas
most CHD occurs sporadically [16]. The mechanisms
regulating early heart development and morphogenesis
have been studied extensively in recent years [15]. Given
that dysregulation of heart development is at the root of the
disease, a clear picture of how the heart develops is crucial
to our understanding of the genesis of CHD [1].
Cardiogenesis involves a complex series of coordi-
nated tissue morphogenetic events. During cardiac loop-
ing, the heart tube elongates by the addition of
progenitor cells from the second heart field to generate
the four chambers of the mature heart. Endocardial cells
that overlie the cardiac cushions subsequently undergo
epithelial-to-mesenchymal transformation (EMT) and
ultimately contribute to all the valves and septa of the
mature heart [7]. Cardiac neural crest cells also migrate
into the developing heart and promote normal cardiac
development [9].
A complex network of signaling inputs and transcrip-
tional regulators has recently been shown to control CHD
development. These include fibroblast growth factor
(FGF), bone morphogenetic protein (BMP), Notch, and the
transcription factor Islet-1 (ISL1) [10]. Minor imbalances
in this network during cardiovascular development can
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result in profound CHDs, including septal defects, which
represent the most common CHD [1].
The BMP subclass of transforming growth factor (TGF-
b) signaling molecules includes BMP4. Findings have
shown that the BMP4 signaling molecule is expressed in
the ventral splanchnic and branchial-arch mesoderm and in
the myocardium of the outflow tract in mice, suggesting
that it may play an important role in cardiac development
[12]. Furthermore, BMP4 has been reported to regulate
EMT and cardiac neural crest migration together with
Notch signals as a downstream target of FGF8 [5]. Loss of
BMP4 gene expression in mice resulted in septal defects,
defective endocardial cushion remodeling, and abnormal
semilunar valve formation [14].
Recent studies have suggested that BMP4 directly reg-
ulates a micro RNA (miRNA)-mediated effector mecha-
nism, which in turn downregulates cardiac progenitor
genes and enhances myocardial differentiation by reducing
gene expression of ISL1 and T-box transcription factor 1
(TBX1), which are vital transcription factors for normal
cardiac development [13, 20].
We tested the hypothesis that single nucleotide polymor-
phisms (SNPs) in the BMP4 gene may be associated with
CHD risk by performing genotyping analyses of BMP4
polymorphisms in a case–control study of 575 CHD patients
and 844 control subjects in an ethnic Han Chinese population.
Materials and Methods
Study Population
The study was approved by the institutional review board of
Nanjing Children’s Hospital Affiliated with Nanjing Medi-
cal University, Nanjing, China. In brief, this hospital-based
case–control study included 575 confirmed CHD patients
and 844 non-CHD control subjects. All the CHD patients had
either atrial septal defects (ASDs) or ventricular septal
defects (VSDs) (the most common CHDs) diagnosed by
ultrasound and confirmed in surgical operations.
The CHD patients were recruited consecutively from the
Affiliated Nanjing Children’s Hospital of Nanjing Medical
University, Nanjing, China, between July 2011 and August
2012. Structural malformations involving another organ
system and known chromosomal abnormalities were
excluded in all patients. Additional exclusion criteria
specified a positive family history of CHD in a first-degree
relative (parents, siblings, and children), maternal diabetes
mellitus, phenylketonuria, maternal teratogen exposures
(e.g., pesticides and organic solvents), and maternal ther-
apeutic drug exposure during the intrauterine period.
The control subjects were non-CHD outpatients recruited
from the same hospital during the same period, mostly with a
diagnosis of trauma or infection. Control subjects with con-
genital anomalies were excluded from the study. All the sub-
jects were genetically unrelated ethnic Han Chinese. Informed
consent was obtained directly or from the patient’s parents.
The subjects, their parents, or both were interviewed
personally by trained interviewers using a structured
questionnaire. After the interview, 4 mL of venous blood
was collected from each subject.
SNP Selection and Genotyping
The BMP4 gene is located on chromosome 14q22.2. We
used the public HapMap SNP database (phase 2 ? 3
February 2009 on NCBI B36 assembly, dbSNP b126) to
search for SNPs located in each gene or in the 2-kb
upstream region of the gene with a minor allele frequency
(MAF) of 0.05 or higher in the Han Chinese Han popula-
tion (CHB). We then performed linkage disequilibrium
analysis and defined three SNPs (rs17563, rs2071047,
rs762642) as the tagging SNPs based on an r2 threshold of
0.8 by Haploview software.
DNA Extraction and Genotyping
Genomic DNA was isolated from leukocyte pellets of venous
blood by proteinase K digestion followed by phenol-chlo-
roform extraction as described previously [25]. The SNPs
were genotyped using the TaqMan assay on the ABI PRISM
7900 HT platform (Applied Biosystems, Inc., Foster City,
California). Primers and probes were available on request
(rs2761887-F: TCAGAGCAAGGCCAAGACATC; R: GA
CTTGCCCAAAGCCATACAG; P-C: FAM-TGCCATCTT
TTCCATC-MGB; P-A: HEX-TGCCATATTTTCC-MGB.
rs17563, F: TGCTTTTCGTTTCCTCTTTAACCT; R: ACG
GTGGAAGCCCCTTTC; P-T: FAM-CGAGGTGATCTC
C-MGB; P-C: HEX-TGAGAACGAGGCGAT-MGB. rs207
1047, F: CACGTCTGAGTGCTGTCATTCC; R: TGCTTA
CCTCCAAGAATTTGCA; P-T: FAM-AGCTGCCGCTG
AA-MGB; P-C: HEX-CTGCCGCCGAACT-MGB. rs762
642, F: TGGCGCTGAAAGACCTTTAAA; R :CCAAGGG
CTTCTCTTGTTTCTG; P-G: FAM-CTGGGAGAGTCTC
ACCT-MGB; P-T: HEX-TGGGAGATTCTCACC-MGB).
Genotyping was performed blinded to the case or con-
trol status. Two blank (water) wells in each 384-well plate
were used for quality control, and at least 10 % of the
samples were randomly selected for repeat analysis, which
showed 100 % concordance. All three SNPs were suc-
cessfully genotyped with call rates of 95 % or higher.
Statistical Analyses
Differences in the distributions of genotype frequencies of
the polymorphisms between the cases and the control
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subjects were evaluated using chi-square or Student’s t tests.
The Hardy-Weinberg equilibrium was tested by a goodness-
of-fit chi-square test to compare the observed with the
expected genotype frequencies among the control subjects.
Associations between genotype and risk of CHD were esti-
mated by odds ratios (ORs) and 95 % confidence intervals
(CIs) from logistic regression analyses. All statistical anal-
yses were performed using Statistical Analysis System
software (v.9.1.3e; SAS Institute, Cary, North Carolina).
Results
The characteristics of the CHD patients and the control
subjects are summarized in Table 1. The patients and the
control subjects did not differ significantly in terms of age
or sex. Of the 575 patients with CHD, 165 (28.7 %) had
VSDs and 410 (71.3 %) had ASDs. The genotype distri-
butions of these SNPs in the CHD patients and control
subjects are shown in Table 2.
The observed genotype frequencies for all four variants
were in Hardy-Weinberg equilibrium among the control
subjects. Logistic regression analysis showed that the
BMP4 rs762642 variant genotype was associated with a
significantly increased risk of CHD according to the
additive model (OR, 1.22; 95 % CI, 1.04–1.43). We also
found significant associations in the recessive model (OR,
1.50; 95 % CI, 1.07–2.09) and the co-dominant model
(variant homozygote vs wild-type homozygote: OR, 1.60;
95 % CI, 1.12–2.29). Stratified analyses of these three
SNPs are summarized in Table 3.
The stratified analysis by CHD subtype showed only a
significant association between rs762642 and ASD (ORadd
1.33; 95 % CI 1.04–1.72; Padd = 0.03) in the additive
model. Comparison of variant homozygotes with wild-type
homozygotes in the co-dominant model showed that
rs762642 was significantly associated with risks of ASD
(OR 1.83; 95 % CI 1.06–3.14) and VSD (OR 1.52; 95 %
CI 1.02–2.25). There was no significant heterogeneity
between the subgroups for all the SNPs.
Discussion
The results of this study demonstrated a significantly
increased risk of CHD associated with the BMP4
(rs762642) polymorphism, suggesting that this polymor-
phism may contribute to susceptibility to CHD. Stratified
analysis by CHD subtype indicated that the rs762642
polymorphism conferred susceptibility to ASD. To the best
of our knowledge, this is the first study to evaluate the
association between BMP4 polymorphisms and CHD risk.
The BMP proteins are members of the TGF-b signaling
family, which bind to heterotetrameric receptor complexes
and exert their effects via receptor-mediated activation of
Smad transcription factors [3]. Activated Smads then
translocate to the nucleus to alter the expression of
downstream transcriptional targets and regulate many
aspects of skeletal, cardiovascular, craniofacial, and limb
development [22].
Findings show that BMPs play diverse roles in valve
development and cardiac septation. Myocardial BMP2
activates the expression of hyaluronic acid synthetase 2 to
produce the cushion extracellular matrix required for EMT
[17], whereas the BMP2 and BMP4 receptor BMPR2 plays
various spatial roles. Mice with hypomorphic alleles of
BMPR2 exhibit interruption of the aortic arch, persistent
truncus arteriosus, and missing semilunar valves [2].
The BMP4 gene is located on chromosome 14q22.2. It
comprises four exons and three introns, among which
exons 3 and 4 encode the protein (http://genome.ucsc.edu/
cgi-bin). The BMP4 signaling molecule is expressed in the
ventral splanchnic- and branchial-arch mesoderm and in
the cardiac outflow tract myocardium [12]. Endocardial
cells in defined areas of the outflow tract undergo EMT and
invade the intervening space to form the endocardial
cushions, induced by BMP4. In addition, BMP4 also
induces the cardiac neural crest to invade the forming
aortopulmonary septum and outflow tract cushions [8].
High et al. [5] reported that Notch signals affected EMT
and induced the neural crest by regulating FGF8, which
functioned within the second heart field to regulate
downstream cascades including BMP4, suggesting that
multiple signaling inputs participate in cardiac develop-
ment [5]. Inactivation of BMP4 within the myocardium
results in neonatal lethality as a result of severe defects in
septation and valve diseases such as ASD and VSD.
Recent studies have suggested that BMP4 may directly
regulate an miRNA-mediated effector mechanism that
downregulates cardiac progenitor genes and enhances
myocardial differentiation by reducing expression of ISL1
and TBX1 [20]. The transcription factor ISL1 marks car-
diac progenitor cells and generates diverse multipotent
cardiovascular cell lineages, directing complex cardiac
morphogenesis. During cardiac development, ISL1 clearly
Table 1 Demographic and Selected variables among patients with
congenital heart disease (CHD) and control subjects
CHD n (%) Controls n (%) P Value
CHD classification 575 ¯ \0.001
VSD 410 (71.3) ¯
ASD 165 (28.7) ¯
Sex 575 844 0.52
Male 296 (51.5) 420 (49.8)
Female 279 (48.5) 424 (50.2)
Mean age (years) 6.86 ± 4.34 6.59 ± 4.81 0.28
VSD ventricular septal defect, ASD atrial septal defect
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acts as an upstream transcription factor capable of acti-
vating various downstream targets.
The dosage-sensitive regulator TBX1 plays a critical role
in heart development. Mutations in the TBX1 gene have been
associated with major phenotypes in 22q11 deletion syn-
dromes such as DiGeorge syndrome, conotruncal anomaly
face syndrome, and velo-cardiofacial syndrome. These
mutations also feature in thymic hypoplasia, parathyroid
hypoplasia, and cardiac defects such as VSD, tetralogy of
Fallot, and double-outflow right ventricle [18]. In heart
development, TBX1 interacts with signaling molecules and
transcription factors to regulate its downstream target genes
[21]. Normal cardiac development involves a network of
complex interconnected signaling pathways and transcrip-
tion factors designed to balance proliferation, migration, and
subsequent differentiation and to minimize errors [4, 23]. As
a vital part of this complex network, BMP4 regulates cardiac
normal development, which includes multiple signaling
inputs and transcription factors.
Lin et al. [11] recently demonstrated significant differ-
ences in the genotype and allele distributions of the 538T/C
(rs17563) polymorphism of the BMP4 gene among patients
with nonsyndromic cleft lip with or without cleft palate
(NSCLP) and control subjects in Chinese children. The 538
C allele carriers had a significantly greater risk of NSCLP
than the noncarriers.
In a Chilean study, the BMP4 (rs762642) G/T poly-
morphism was significantly associated with NSCLP cases
[19]. However, no previous studies have addressed the
association between BMP4 polymorphisms and CHD
susceptibility.
The BMP4 promoter region contains the elements that
control the initiation and regulation of transcription. The
SNP rs762642 is located within the first intron of BMP4
near the promoter and an enhancer region. Previous
research showed functional SNPs in the noncoding region
of folate-related genes in birth defects. We therefore
hypothesized that the BMP4 rs762642 polymorphism could
have a functional effect on BMP4 expression or protein
activity, causing an imbalance in the network responsible
for regulating normal cardiac development [24]. The BMP4
rs2071047 polymorphism is located in the intron region,
but we found no significant association between this SNP
and CHD risk.
Our study had certain limitations. It analyzed a hospital-
based population and may therefore have been subject to
selection bias of subjects associated with a particular
genotype. The control patients were non-CHD outpatients
from the same geographic area. Further functional studies
are needed to validate our current findings. In addition, this
study was conducted with a Han Chinese population, and
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In conclusion, the results of this study indicate that the
BMP4 rs762642 C polymorphism may confer susceptibility
to sporadic CHD. Stratified analysis by CHD subtype
suggests that the rs762642 polymorphism contributes to
susceptibilities to both ASD and VSD. However, the
sample size was moderate, so the statistical power of the
study was limited. Larger population-based, prospective
studies are needed to clarify the impact of BMP4 poly-
morphisms on CHD susceptibility. In addition to providing
new insights into the variety of CHD phenotypes, our
observations also may provide the basis for a more inte-
grated understanding concerning the molecular basis of
human CHD and will increase our appreciation of inter-
actions among regulatory pathways and of how the heart
can compensate for imbalances.
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